Cargando…

Digital vasculitis in a patient with rheumatoid arthritis: good response on anti-TNF blockade

Detalles Bibliográficos
Autores principales:	van den Hoogen, F, den Broeder, A, Zandbelt, M, van de Putte, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273296/ http://dx.doi.org/10.1186/ar262

Ejemplares similares

IL-18 blockade is a potential disease-modifying therapy for rheumatoid arthritis
por: Plater-Zyberk, C, et al.
Publicado: (2001)

Altered migratory capacity of polymorphonuclear leucocytes as an effect of TNF-alpha blockade in patients with rheumatoid arthritis
por: Mitterhammer, H, et al.
Publicado: (2001)

Rheumatoid Arthritis is a Lining Cell Disease: An Evolving Concept
por: van de Putte, Leo BA, et al.
Publicado: (2000)

Influence of anti-TNF therapy on monocyte gene expression in rheumatoid arthritis
por: Hernandez, M, et al.
Publicado: (2003)

IL-18 expression in synovial biopsies of patients with active rheumatoid arthritis is associated with enhanced levels of both IL-1 and TNFα
por: Joosten, LAB, et al.
Publicado: (2002)

Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
por: Tweehuysen, Lieke, et al.
Publicado: (2018)

High dose cyclophosphamide followed by autologous stem cell transplantation for the treatment of intractable rheumatoid arthritis (RA): a 2-year clinical and immunological follow-up
por: Verburg, RJ, et al.
Publicado: (2002)

What causes a small increase in radiographic progression in rheumatoid arthritis patients tapering TNF inhibitors?
por: Bouman, Chantal A M, et al.
Publicado: (2017)

Chemokine blockade in patients with rheumatoid arthritis: reduction of synovial inflammation
por: Haringman, JJ, et al.
Publicado: (2002)

New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?
por: Feldmann, M, et al.
Publicado: (2001)

HLA-DRB1 encoded predisposition to rheumatoid arthritis: the anchor hypothesis
por: de Vries, N, et al.
Publicado: (2004)

Citrullination of synovial proteins in murine models of rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Dose REduction strategy of subcutaneous TNF inhibitors in rheumatoid arthritis: design of a pragmatic randomised non inferiority trial, the DRESS study
por: den Broeder, Alfons A, et al.
Publicado: (2013)

Adjustment in anti-TNF therapy after initial response: long-term follow-up in patients with rheumatoid arthritis
por: Sidiropoulos, P, et al.
Publicado: (2003)

A customized monocyte cDNA microarray for diagnosis of rheumatoid arthritis and prognosis of anti-TNF-α therapy
por: Stuhlmüller, B, et al.
Publicado: (2004)

TNF-α dependency of IL-17-induced joint pathology differs under naive and arthritis conditions in vivo
por: Koenders, M, et al.
Publicado: (2003)

Infiltrate analysis of rheumatoid synovial tissue before and after high does chemotherapy and autologous stem cell transplantation
por: Verburg, RJ, et al.
Publicado: (2001)

Effects of anti-TNF therapy on endothelial function and intima–media thickness of common carotid artery in patients with rheumatoid arthritis
por: Siakka, P, et al.
Publicado: (2004)

AKT regulates TNF-alpha-mediated apoptosis of rheumatoid arthritis synovial fibroblasts
por: Mountz, JD, et al.
Publicado: (2001)

Prediction of response to anti-TNF treatment using laboratory biomarkers in patients with rheumatoid arthritis: a systematic review
por: Wientjes, Maike H M, et al.
Publicado: (2022)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Circulating bioactive TNF in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, H, et al.
Publicado: (2003)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Genome-wide gene expression in experimental arthritis: defining new targets of chronic/destructive rheumatoid arthritis (RA)
por: Takahashi, N, et al.
Publicado: (2002)

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
por: Radstake, TRDJ, et al.
Publicado: (2004)

TNF-α blockade in early rheumatoid significantly reduces serum VEGF and ultrasonographic measures of synovitis and joint vascularity by 18 weeks
por: Taylor, PC, et al.
Publicado: (2002)

Polymorphism at the position -308 of TNF-α gene influences outcome of infliximab therapy in rheumatoid arthritis
por: Mugnier, B, et al.
Publicado: (2004)

Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
por: van den Bemt, Bart JF, et al.
Publicado: (2011)

Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial
por: den Broeder, Alfons A., et al.
Publicado: (2017)

Reshaping the shared epitope hypothesis: HLA-associated risk for rheumatoid arthritis is encoded by amino acid substitutions at position 67 to 74 of the HLA-DRB1 molecule
por: de Vries, N, et al.
Publicado: (2002)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

Obstacles to Anti-CD4 Therapy in Rheumatoid Arthritis
por: Kalden, Joachim R, et al.
Publicado: (2000)

Epstein–Barr virus load follow up in rheumatoid arthritis patients treated with TNF-α inhibitors
por: Balandraud, N, et al.
Publicado: (2004)

Anti-α-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome
por: Zandbelt, Michiel M, et al.
Publicado: (2004)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Increased expression of chemokines DC-CK1, ELC and TARC by dendritic cells and in synovium from patients with rheumatoid arthritis
por: Radstake, T, et al.
Publicado: (2004)

Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor (VEGF) levels in patients with rheumatoid arthritis: a pilot study
por: Strunk, J, et al.
Publicado: (2004)

The Role of TNFα in the Pathogenesis of Rheumatoid Synovitis
por: Maini, Ravinder N, et al.
Publicado: (2000)

Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy
por: Cestelli, Valentina, et al.
Publicado: (2014)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_8cjk30mfmdd4mmi0h61s2nqhhq